Comments
Loading...

Humacyte

HUMANASDAQ
Logo brought to you by Benzinga Data
$5.20
-0.25-4.59%
At Close: -
$5.35
0.152.88%
After Hours: 4:49 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$25.00
Lowest Price Target1
$3.00
Consensus Price Target1
$12.22

Humacyte (NASDAQ:HUMA) Stock, Analyst Ratings, Price Targets, Forecasts

Humacyte Inc has a consensus price target of $12.22 based on the ratings of 9 analysts. The high is $25 issued by EF Hutton on September 9, 2024. The low is $3 issued by Piper Sandler on November 10, 2023. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, EF Hutton, and Benchmark on September 20, 2024, September 9, 2024, and September 5, 2024, respectively. With an average price target of $17.67 between Cantor Fitzgerald, EF Hutton, and Benchmark, there's an implied 230.22% upside for Humacyte Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
1
Jul
0
0
0
0
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
EF Hutton
Benchmark
BTIG
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Humacyte

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Humacyte (HUMA) stock?

A

The latest price target for Humacyte (NASDAQ:HUMA) was reported by Cantor Fitzgerald on September 20, 2024. The analyst firm set a price target for $13.00 expecting HUMA to rise to within 12 months (a possible 142.99% upside). 18 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Humacyte (HUMA)?

A

The latest analyst rating for Humacyte (NASDAQ:HUMA) was provided by Cantor Fitzgerald, and Humacyte reiterated their overweight rating.

Q

When was the last upgrade for Humacyte (HUMA)?

A

There is no last upgrade for Humacyte

Q

When was the last downgrade for Humacyte (HUMA)?

A

There is no last downgrade for Humacyte.

Q

When is the next analyst rating going to be posted or updated for Humacyte (HUMA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humacyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humacyte was filed on September 20, 2024 so you should expect the next rating to be made available sometime around September 20, 2025.

Q

Is the Analyst Rating Humacyte (HUMA) correct?

A

While ratings are subjective and will change, the latest Humacyte (HUMA) rating was a reiterated with a price target of $13.00 to $13.00. The current price Humacyte (HUMA) is trading at is $5.35, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch